Literature DB >> 23361085

Predictors of preterm birth in patients with mild systemic lupus erythematosus.

Megan E B Clowse1, Daniel J Wallace, Michael Weisman, Andra James, Lisa G Criscione-Schreiber, David S Pisetsky.   

Abstract

OBJECTIVE: While increased disease activity is the best predictor of preterm birth in women with systemic lupus erythematosus (SLE), even women with low disease activity are at increased risk of this complication. Biomarkers that would identify at-risk pregnancies could allow interventions to prevent preterm birth.
METHOD: Measures of SLE activity, inflammation, placental health and renal function between 20 and 28 weeks gestation (mid-gestation) were correlated to preterm birth and gestational age at delivery in a prospective cohort of pregnant women with SLE. RESULT: Of the 40 pregnancies in 39 women, all with mild-moderate SLE disease, 9 (23.7%) of the 38 live births were delivered preterm. Low C4 was the only marker of SLE activity associated with younger gestational age at delivery. Elevated ferritin and lower oestradiol correlated with younger gestational age at delivery. Renal function remained normal during all pregnancies at mid-gestation and did not correlate with preterm birth. Higher serum uric acid, however, correlated with younger gestational age at delivery.
CONCLUSIONS: In women with SLE with mild-moderate disease activity, ferritin, oestradiol and uric acid levels at mid-gestation may predict preterm birth. These markers may prove to be clinically useful in identifying pregnancies at particularly high risk for adverse outcomes.

Entities:  

Keywords:  Autoimmune Diseases; Disease Activity; Systemic Lupus Erythematosus

Mesh:

Substances:

Year:  2013        PMID: 23361085     DOI: 10.1136/annrheumdis-2012-202449

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

Review 1.  Risk factors of systemic lupus erythematosus flares during pregnancy.

Authors:  Luis J Jara; Gabriela Medina; Pilar Cruz-Dominguez; Carmen Navarro; Olga Vera-Lastra; Miguel A Saavedra
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 2.  Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation.

Authors:  Vikki M Abrahams; Lawrence W Chamley; Jane E Salmon
Journal:  Arthritis Rheumatol       Date:  2017-07-18       Impact factor: 10.995

3.  Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.

Authors:  Jill P Buyon; Mimi Y Kim; Marta M Guerra; Carl A Laskin; Michelle Petri; Michael D Lockshin; Lisa Sammaritano; D Ware Branch; T Flint Porter; Allen Sawitzke; Joan T Merrill; Mary D Stephenson; Elisabeth Cohn; Lamya Garabet; Jane E Salmon
Journal:  Ann Intern Med       Date:  2015-08-04       Impact factor: 25.391

Review 4.  Systemic Lupus Erythematosus and Pregnancy: A Brief Review.

Authors:  Deepan S Dalal; Khyati A Patel; Madhuri A Patel
Journal:  J Obstet Gynaecol India       Date:  2019-03-12

5.  Adverse Perinatal Outcomes Before and After Diagnosis of Systemic Lupus Erythematosus Among African American Women.

Authors:  Meghan Angley; Carolyn Drews-Botsch; Tené T Lewis; Martina Badell; S Sam Lim; Penelope P Howards
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-04-05       Impact factor: 5.178

6.  Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosus.

Authors:  Yuri Hiramatsu; Kentaro Isoda; Takuya Kotani; Eri Nakamura; Yumiko Wada; Youhei Fujiki; Shigeki Makino; Daisuke Fujita; Tohru Takeuchi
Journal:  Arthritis Res Ther       Date:  2021-05-12       Impact factor: 5.156

7.  Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus.

Authors:  Zhongping Zhan; Ying Yang; Yanfeng Zhan; Dongying Chen; Liuqin Liang; Xiuyan Yang
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240

Review 8.  An ever-challenging relationship: lupus and pregnancy.

Authors:  Andra Bălănescu; Teodora Donisan; Dinu Bălănescu
Journal:  Reumatologia       Date:  2017-03-22

9.  EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.

Authors:  L Andreoli; G K Bertsias; N Agmon-Levin; S Brown; R Cervera; N Costedoat-Chalumeau; A Doria; R Fischer-Betz; F Forger; M F Moraes-Fontes; M Khamashta; J King; A Lojacono; F Marchiori; P L Meroni; M Mosca; M Motta; M Ostensen; C Pamfil; L Raio; M Schneider; E Svenungsson; M Tektonidou; S Yavuz; D Boumpas; A Tincani
Journal:  Ann Rheum Dis       Date:  2016-07-25       Impact factor: 19.103

Review 10.  The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy.

Authors:  Cecilia Beatrice Chighizola; Paola Adele Lonati; Laura Trespidi; Pier Luigi Meroni; Francesco Tedesco
Journal:  Front Immunol       Date:  2020-08-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.